Hem › Bukspottkörtelcancer › Michigan › Ann Arbor
Kliniska studier för Bukspottkörtelcancer i Ann Arbor, MI
14 studier för Bukspottkörtelcancer söker deltagare vid platser i och runt Ann Arbor (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
RekryterarFas 3
- Investigative Site US006, Ann Arbor
- Investigative Site US012, Ypsilanti · 7 mi bort
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
RekryterarFas 3
- University of Michigan Health - University of Michigan Medical Center, Ann Arbor
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RekryterarFas 1/2
- University of Michigan Medical School Rogel Cancer Center, Ann Arbor
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
RekryterarFas 2
- Local Institution - 0119, Ann Arbor
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RekryterarObservationsstudie
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi bort
- och 5 fler
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
RekryterarFas 2
- University of Michigan, Ann Arbor
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RekryterarFas 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi bort
- och 5 fler
Pancreatic Cancer Early Detection Consortium
RekryterarObservationsstudieFriska volontärer välkomna
- University of Michigan, Ann Arbor
A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer
RekryterarFas 1
- University of Michigan Health, Ann Arbor
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RekryterarFas 1/2
- University of Michigan, Ann Arbor
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RekryterarFas 2
- Ohio State University-Telemedicine, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Ann Arbor
The Cancer of the Pancreas Screening-5 CAPS5)Study
RekryterarFas 3
- University of Michigan, Ann Arbor
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
RekryterarFas 1/2
- University of Michigan, Ann Arbor
Bukspottkörtelcancer-studier i andra städer
- Houston, TX61 studier
- New York City, NY60 studier
- Boston, MA43 studier
- Nashville, TN39 studier
- Los Angeles, CA35 studier
- St. Louis, MO33 studier
- Arlington, VA33 studier
- Baltimore, MD31 studier
- San Antonio, TX31 studier
- Philadelphia, PA26 studier
- Tampa, FL26 studier
- Durham, NC24 studier
Andra studier i Ann Arbor
- Bröstcancer27 studier
- Prostatacancer27 studier
- Icke-småcellig lungcancer26 studier
- Cancer (alla typer)25 studier
- Lungcancer23 studier
- Kolorektal cancer23 studier
- Hjärtsvikt22 studier
- Akut myeloid leukemi17 studier
- Hjärt-kärlsjukdom16 studier
- Melanom12 studier
- Stroke12 studier
- Plattenepitelcancer i huvud och hals12 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.